Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Clinical trial NCT06654037 · RECRUITING
Trial details
- NCT number
- NCT06654037
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-18
- Primary completion
- 2027-04-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.